BrightSpring Health Services (BTSGU) Financials

$81.05 -1.85 (-2.23%)

As of 05/23/2025 04:00 PM Eastern

Annual Income Statements for BrightSpring Health Services

This table shows BrightSpring Health Services' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-18	-155	-54
Consolidated Net Income / (Loss)	-21	-157	-54
Net Income / (Loss) Continuing Operations	-21	-157	-54
Total Pre-Tax Income	-35	-177	-46
Total Operating Income	206	147	188
Total Gross Profit	1,588	1,434	1,354
Total Revenue	11,266	8,826	7,721
Operating Revenue	11,266	8,826	7,721
Total Cost of Revenue	9,678	7,392	6,366
Operating Cost of Revenue	9,678	7,392	6,366
Total Operating Expenses	1,382	1,287	1,166
Selling, General & Admin Expense	1,382	1,287	1,126
Impairment Charge	0.00	0.00	41
Total Other Income / (Expense), net	-241	-325	-234
Interest Expense	241	325	234
Income Tax Expense	-14	-21	8.47
Net Income / (Loss) Attributable to Noncontrolling Interest	-2.46	-2.23	-0.31
Basic Earnings per Share	($0.09)	($1.31)	($0.46)
Weighted Average Basic Shares Outstanding	193.00M	117.87M	117.84M
Diluted Earnings per Share	($0.09)	($1.31)	($0.46)
Weighted Average Diluted Shares Outstanding	193.00M	117.87M	117.84M
Weighted Average Basic & Diluted Shares Outstanding	174.97M	-	-

This table shows BrightSpring Health Services' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Net Income / (Loss) Attributable to Common Shareholders	30	16	-8.23	20	-46	-6.54	-131	3.99	-21
Consolidated Net Income / (Loss)	29	15	-8.98	19	-46	-7.20	-130	2.77	-22
Net Income / (Loss) Continuing Operations	9.22	15	-8.98	19	-46	-7.20	-130	2.77	-22
Total Pre-Tax Income	8.98	24	0.78	9.98	-70	-15	-136	-0.07	-27
Total Operating Income	51	79	57	62	8.07	68	-52	80	52
Total Gross Profit	338	422	408	389	369	369	358	372	335
Total Revenue	2,878	3,053	2,907	2,730	2,577	2,375	2,257	2,167	2,028
Operating Revenue	2,878	3,053	2,907	2,730	2,577	2,375	2,257	2,167	2,028
Total Cost of Revenue	2,540	2,631	2,499	2,341	2,207	2,006	1,898	1,795	1,694
Operating Cost of Revenue	2,540	2,631	2,499	2,341	2,207	2,006	1,898	1,795	1,694
Total Operating Expenses	288	343	351	327	361	300	411	292	283
Selling, General & Admin Expense	288	343	351	327	361	300	411	292	283
Total Other Income / (Expense), net	-42	-55	-56	-52	-78	-83	-84	-80	-78
Interest Expense	42	55	56	52	78	83	84	80	78
Income Tax Expense	-0.24	8.78	9.76	-9.47	-23	-7.59	-5.81	-2.83	-4.35
Net Income / (Loss) Discontinued Operations	20	-	-	-	-	-	-	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.53	-0.60	-0.75	-0.48	-0.64	-0.66	0.55	-1.22	-0.89
Basic Earnings per Share	$0.15	$0.11	($0.04)	$0.10	($0.26)	($0.05)	($1.11)	$0.03	($0.18)
Weighted Average Basic Shares Outstanding	201.01M	193.00M	198.49M	197.52M	175.53M	117.87M	117.86M	117.88M	117.87M
Diluted Earnings per Share	$0.14	$0.11	($0.04)	$0.10	($0.26)	($0.05)	($1.11)	$0.03	($0.18)
Weighted Average Diluted Shares Outstanding	214.93M	193.00M	198.49M	208.99M	175.53M	117.87M	117.86M	126.45M	117.87M
Weighted Average Basic & Diluted Shares Outstanding	174.25M	174.97M	174.13M	171.46M	171.32M	0.00	-	-	-

This table details how cash moves in and out of BrightSpring Health Services' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	48	-0.56	-33
Net Cash From Operating Activities	24	211	-4.65
Net Cash From Continuing Operating Activities	24	211	-4.65
Net Income / (Loss) Continuing Operations	-21	-157	-54
Consolidated Net Income / (Loss)	-21	-157	-54
Depreciation Expense	204	202	204
Amortization Expense	12	21	20
Non-Cash Adjustments To Reconcile Net Income	124	38	78
Changes in Operating Assets and Liabilities, net	-296	107	-252
Net Cash From Investing Activities	-140	-134	45
Net Cash From Continuing Investing Activities	-140	-134	45
Purchase of Property, Plant & Equipment	-81	-74	-70
Acquisitions	-60	-63	-42
Divestitures	0.00	0.00	156
Other Investing Activities, net	0.47	2.15	2.14
Net Cash From Financing Activities	165	-77	-74
Net Cash From Continuing Financing Activities	165	-77	-74
Repayment of Debt	-3,443	-30	-41
Repurchase of Preferred Equity	0.00	-10	0.00
Repurchase of Common Equity	-2.97	-0.65	0.00
Payment of Dividends	0.00	0.00	-0.75
Issuance of Debt	2,968	-24	-17
Issuance of Common Equity	658	1.33	0.23
Other Financing Activities, net	-15	-13	-15
Cash Interest Paid	211	304	213
Cash Income Taxes Paid	25	37	29

This table details how cash moves in and out of BrightSpring Health Services' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Net Change in Cash & Equivalents	-8.61	25	11	-33	45	1.43	0.39	0.08	-2.45
Net Cash From Operating Activities	102	91	27	-15	-79	162	34	-25	40
Net Cash From Continuing Operating Activities	102	91	27	-15	-79	162	34	-25	40
Net Income / (Loss) Continuing Operations	29	15	-8.98	19	-46	-7.20	-130	2.77	-22
Consolidated Net Income / (Loss)	29	15	-8.98	19	-46	-7.20	-130	2.77	-22
Depreciation Expense	42	55	51	50	49	51	51	50	50
Amortization Expense	2.75	2.63	2.54	2.49	4.45	5.23	5.18	5.31	5.20
Non-Cash Adjustments To Reconcile Net Income	29	30	27	21	46	7.49	9.62	10	10
Changes in Operating Assets and Liabilities, net	-1.09	-12	-44	-108	-132	106	98	-94	-3.39
Net Cash From Investing Activities	-24	-16	-36	-58	-31	-17	-55	-45	-17
Net Cash From Continuing Investing Activities	-24	-16	-36	-58	-31	-17	-55	-45	-17
Purchase of Property, Plant & Equipment	-18	-15	-20	-24	-22	-17	-18	-21	-18
Acquisitions	-6.75	-0.04	-16	-34	-9.39	-0.55	-37	-25	0.00
Other Investing Activities, net	0.20	-0.43	0.36	0.27	0.27	0.36	0.30	1.11	0.38
Net Cash From Financing Activities	-86	-50	20	40	155	-144	21	71	-25
Net Cash From Continuing Financing Activities	-86	-50	20	40	155	-144	21	71	-25
Repayment of Debt	-75	-16	-14	-2,527	-887	-7.58	-7.54	6.76	-22
Repurchase of Common Equity	-5.10	-	-2.02	-0.33	-0.63	-0.33	-0.33	-	0.00
Issuance of Debt	0.00	-34	41	2,571	389	-122	32	67	0.00
Issuance of Common Equity	0.35	1.00	0.13	0.40	656	0.74	0.45	0.06	0.09
Other Financing Activities, net	-6.17	-1.20	-6.22	-4.13	-3.08	-4.42	-2.90	-2.84	-2.89
Cash Interest Paid	54	46	54	51	60	78	78	74	73
Cash Income Taxes Paid	0.25	0.64	0.62	13	11	1.86	9.08	23	3.73

This table presents BrightSpring Health Services' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023
Period end date	12/31/2024	12/31/2023
Total Assets	5,926	5,533
Total Current Assets	1,893	1,457
Cash & Equivalents	61	13
Accounts Receivable	1,029	882
Inventories, net	641	403
Prepaid Expenses	163	159
Plant, Property, & Equipment, net	250	246
Total Noncurrent Assets	3,783	3,830
Goodwill	2,672	2,608
Intangible Assets	811	881
Noncurrent Deferred & Refundable Income Taxes	5.58	0.00
Other Noncurrent Operating Assets	294	340
Total Liabilities & Shareholders' Equity	5,926	5,533
Total Liabilities	4,275	4,920
Total Current Liabilities	1,428	1,248
Short-Term Debt	49	32
Accounts Payable	941	642
Accrued Expenses	357	492
Other Current Liabilities	82	82
Total Noncurrent Liabilities	2,846	3,672
Long-Term Debt	2,562	3,332
Capital Lease Obligations	25	224
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	24
Other Noncurrent Operating Liabilities	259	92
Redeemable Noncontrolling Interest	3.73	27
Total Equity & Noncontrolling Interests	1,648	585
Total Preferred & Common Equity	1,648	585
Preferred Stock	0.00	0.00
Total Common Equity	1,648	585
Common Stock	1,869	773
Retained Earnings	-222	-200
Accumulated Other Comprehensive Income / (Loss)	1.42	13
Noncontrolling Interest	0.00	0.67

This table presents BrightSpring Health Services' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024
Total Assets	5,847	5,786	5,605	5,656
Total Current Assets	2,528	1,710	1,522	1,573
Cash & Equivalents	52	36	25	58
Accounts Receivable	975	1,026	985	991
Inventories, net	534	478	374	374
Prepaid Expenses	131	170	138	150
Other Current Nonoperating Assets	836	-	-	-
Plant, Property, & Equipment, net	177	249	246	246
Total Noncurrent Assets	3,141	3,828	3,838	3,837
Goodwill	2,370	2,673	2,626	2,609
Intangible Assets	568	842	851	856
Noncurrent Deferred & Refundable Income Taxes	2.31	6.68	22	11
Other Noncurrent Operating Assets	201	306	338	361
Other Noncurrent Nonoperating Assets	0.00	-	-	-
Total Liabilities & Shareholders' Equity	5,847	5,786	5,605	5,656
Total Liabilities	4,156	4,167	3,999	4,081
Total Current Liabilities	1,458	1,264	1,145	1,245
Short-Term Debt	49	49	49	49
Accounts Payable	868	784	669	656
Accrued Expenses	303	349	347	452
Other Current Liabilities	42	82	80	89
Other Current Nonoperating Liabilities	196	-	-	-
Total Noncurrent Liabilities	2,699	2,903	2,854	2,836
Long-Term Debt	2,489	2,609	2,564	2,515
Capital Lease Obligations	137	221	220	24
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	0.00	0.00	0.00
Other Noncurrent Operating Liabilities	73	74	71	297
Other Noncurrent Nonoperating Liabilities	0.00	-	-	-
Redeemable Noncontrolling Interest	3.32	4.13	5.94	6.28
Total Equity & Noncontrolling Interests	1,687	1,615	1,600	1,568
Total Preferred & Common Equity	1,687	1,615	1,600	1,567
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	1,687	1,615	1,600	1,567
Common Stock	1,882	1,850	1,807	1,790
Retained Earnings	-193	-234	-226	-246
Accumulated Other Comprehensive Income / (Loss)	-1.87	-0.71	19	23
Noncontrolling Interest	-0.13	0.20	0.38	0.52

This table displays calculated financial ratios and metrics derived from BrightSpring Health Services' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	27.65%	14.32%	0.00%
EBITDA Growth	14.18%	-10.14%	0.00%
EBIT Growth	40.22%	-21.64%	0.00%
NOPAT Growth	40.22%	-21.64%	0.00%
Net Income Growth	86.92%	-189.26%	0.00%
EPS Growth	93.13%	-184.78%	0.00%
Operating Cash Flow Growth	-88.72%	4,630.05%	0.00%
Free Cash Flow Firm Growth	102.61%	0.00%	0.00%
Invested Capital Growth	0.91%	0.00%	0.00%
Revenue Q/Q Growth	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-5.28%	0.00%	0.00%
Profitability Metrics	-	-	-
Gross Margin	14.10%	16.24%	17.54%
EBITDA Margin	3.75%	4.20%	5.34%
Operating Margin	1.83%	1.67%	2.43%
EBIT Margin	1.83%	1.67%	2.43%
Profit (Net Income) Margin	-0.18%	-1.78%	-0.70%
Tax Burden Percent	59.07%	88.40%	118.50%
Interest Burden Percent	-16.83%	-120.54%	-24.36%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	3.43%	4.92%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.93%	-9.62%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-5.25%	-56.13%	0.00%
Return on Equity (ROE)	-1.81%	-51.21%	0.00%
Cash Return on Invested Capital (CROIC)	2.53%	-195.08%	0.00%
Operating Return on Assets (OROA)	3.60%	2.66%	0.00%
Return on Assets (ROA)	-0.36%	-2.83%	0.00%
Return on Common Equity (ROCE)	-1.79%	-48.88%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-1.25%	-26.82%	0.00%
Net Operating Profit after Tax (NOPAT)	144	103	131
NOPAT Margin	1.28%	1.17%	1.70%
Net Nonoperating Expense Percent (NNEP)	5.37%	14.54%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	3.37%	2.47%	-
Cost of Revenue to Revenue	85.90%	83.76%	82.46%
SG&A Expenses to Revenue	12.27%	14.58%	14.58%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	12.27%	14.58%	15.11%
Earnings before Interest and Taxes (EBIT)	206	147	188
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	423	370	412
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.80	1.19	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.26	0.08	0.09
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.31	1.03	0.00
Enterprise Value to Revenue (EV/Rev)	0.49	0.49	0.00
Enterprise Value to EBITDA (EV/EBITDA)	13.11	11.60	0.00
Enterprise Value to EBIT (EV/EBIT)	26.86	29.19	0.00
Enterprise Value to NOPAT (EV/NOPAT)	38.37	41.70	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	233.17	20.38	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	52.08	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	1.60	5.86	0.00
Long-Term Debt to Equity	1.57	5.81	0.00
Financial Leverage	2.72	5.84	0.00
Leverage Ratio	5.06	9.03	0.00
Compound Leverage Factor	-0.85	-10.89	0.00
Debt to Total Capital	61.48%	85.42%	0.00%
Short-Term Debt to Total Capital	1.14%	0.77%	0.00%
Long-Term Debt to Total Capital	60.34%	84.65%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.09%	0.66%	0.00%
Common Equity to Total Capital	38.44%	13.92%	0.00%
Debt to EBITDA	6.23	9.69	0.00
Net Debt to EBITDA	6.09	9.65	0.00
Long-Term Debt to EBITDA	6.12	9.60	0.00
Debt to NOPAT	18.24	34.83	0.00
Net Debt to NOPAT	17.82	34.70	0.00
Long-Term Debt to NOPAT	17.91	34.52	0.00
Altman Z-Score	2.47	1.76	0.00
Noncontrolling Interest Sharing Ratio	1.39%	4.54%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	1.33	1.17	0.00
Quick Ratio	0.76	0.72	0.00
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	106	-4,085	0.00
Operating Cash Flow to CapEx	29.38%	286.67%	-6.64%
Free Cash Flow to Firm to Interest Expense	0.44	-12.58	0.00
Operating Cash Flow to Interest Expense	0.10	0.65	-0.02
Operating Cash Flow Less CapEx to Interest Expense	-0.24	0.42	-0.32
Efficiency Ratios	-	-	-
Asset Turnover	1.97	1.60	0.00
Accounts Receivable Turnover	11.80	10.01	0.00
Inventory Turnover	18.55	18.35	0.00
Fixed Asset Turnover	45.41	35.89	0.00
Accounts Payable Turnover	12.23	11.52	0.00
Days Sales Outstanding (DSO)	30.94	36.46	0.00
Days Inventory Outstanding (DIO)	19.67	19.89	0.00
Days Payable Outstanding (DPO)	29.85	31.68	0.00
Cash Conversion Cycle (CCC)	20.77	24.67	0.00
Capital & Investment Metrics	-	-	-
Invested Capital	4,226	4,188	0.00
Invested Capital Turnover	2.68	4.22	0.00
Increase / (Decrease) in Invested Capital	38	4,188	0.00
Enterprise Value (EV)	5,543	4,296	0.00
Market Capitalization	2,965	693	693
Book Value per Share	$9.46	$4.96	$0.00
Tangible Book Value per Share	($10.54)	($24.65)	$0.00
Total Capital	4,287	4,201	0.00
Total Debt	2,636	3,588	0.00
Total Long-Term Debt	2,587	3,556	0.00
Net Debt	2,574	3,575	0.00
Capital Expenditures (CapEx)	81	74	70
Debt-free, Cash-free Net Working Capital (DFCFNWC)	452	227	0.00
Debt-free Net Working Capital (DFNWC)	513	240	0.00
Net Working Capital (NWC)	465	208	0.00
Net Nonoperating Expense (NNE)	165	260	186
Net Nonoperating Obligations (NNO)	2,574	3,575	0.00
Total Depreciation and Amortization (D&A)	217	223	224
Debt-free, Cash-free Net Working Capital to Revenue	4.01%	2.58%	0.00%
Debt-free Net Working Capital to Revenue	4.56%	2.72%	0.00%
Net Working Capital to Revenue	4.12%	2.36%	0.00%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.09)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	193.00M	0.00	0.00
Adjusted Diluted Earnings per Share	($0.09)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	193.00M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	174.97M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	144	103	160
Normalized NOPAT Margin	1.28%	1.17%	2.07%
Pre Tax Income Margin	-0.31%	-2.01%	-0.59%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.86	0.45	0.80
NOPAT to Interest Expense	0.60	0.32	0.56
EBIT Less CapEx to Interest Expense	0.52	0.23	0.50
NOPAT Less CapEx to Interest Expense	0.26	0.09	0.26
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	-1.38%
Augmented Payout Ratio	-14.45%	-0.41%	-1.38%

This table displays calculated financial ratios and metrics derived from BrightSpring Health Services' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	25.92%	28.56%	28.82%	26.01%	27.03%	0.00%	0.00%	0.00%	0.00%
EBITDA Growth	151.48%	9.69%	2,870.24%	-14.92%	-42.64%	0.00%	0.00%	0.00%	0.00%
EBIT Growth	430.87%	15.81%	208.78%	-21.61%	-84.35%	0.00%	0.00%	0.00%	0.00%
NOPAT Growth	585.31%	5.36%	-1,691.56%	118.27%	-84.35%	0.00%	0.00%	0.00%	0.00%
Net Income Growth	162.54%	313.91%	93.10%	602.86%	-108.23%	0.00%	0.00%	0.00%	0.00%
EPS Growth	153.85%	320.00%	96.40%	233.33%	-44.44%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	228.84%	-44.20%	-19.13%	39.59%	-297.66%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Growth	111.75%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Growth	-10.51%	0.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Revenue Q/Q Growth	-5.72%	5.02%	6.47%	5.96%	0.00%	5.23%	4.14%	6.82%	0.00%
EBITDA Q/Q Growth	-29.96%	24.16%	-4.34%	87.15%	0.00%	3,262.11%	-97.26%	26.18%	0.00%
EBIT Q/Q Growth	-35.82%	39.08%	-8.93%	673.70%	0.00%	230.64%	-165.63%	54.43%	0.00%
NOPAT Q/Q Growth	3.47%	107.68%	-638.71%	2,054.16%	0.00%	230.64%	-165.63%	54.43%	0.00%
Net Income Q/Q Growth	88.33%	271.52%	-146.20%	141.91%	0.00%	94.47%	-4,804.41%	112.42%	0.00%
EPS Q/Q Growth	27.27%	375.00%	-140.00%	138.46%	0.00%	95.50%	-3,800.00%	116.67%	0.00%
Operating Cash Flow Q/Q Growth	12.12%	232.57%	278.96%	80.69%	0.00%	382.03%	233.67%	-163.17%	0.00%
Free Cash Flow Firm Q/Q Growth	3,824.87%	100.24%	-19.24%	-4.69%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-13.08%	-5.28%	1.10%	7.51%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	11.76%	13.82%	14.04%	14.25%	14.34%	15.53%	15.88%	17.17%	16.50%
EBITDA Margin	3.32%	4.47%	3.78%	4.21%	2.38%	5.24%	0.16%	6.24%	5.28%
Operating Margin	1.76%	2.59%	1.96%	2.29%	0.31%	2.87%	-2.32%	3.67%	2.54%
EBIT Margin	1.76%	2.59%	1.96%	2.29%	0.31%	2.87%	-2.32%	3.67%	2.54%
Profit (Net Income) Margin	1.01%	0.50%	-0.31%	0.71%	-1.80%	-0.30%	-5.77%	0.13%	-1.10%
Tax Burden Percent	323.20%	63.69%	-1,152.89%	194.90%	66.57%	48.68%	95.73%	-4,067.65%	83.68%
Interest Burden Percent	17.69%	30.60%	1.37%	15.98%	-863.75%	-21.67%	260.14%	-0.09%	-51.64%
Effective Tax Rate	-2.67%	36.31%	1,252.89%	-94.90%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	5.52%	4.42%	0.00%	0.00%	0.00%	4.24%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	4.50%	3.28%	0.00%	0.00%	0.00%	2.70%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	6.22%	8.91%	0.00%	0.00%	0.00%	15.78%	0.00%	0.00%	0.00%
Return on Equity (ROE)	11.74%	13.33%	0.00%	0.00%	0.00%	20.02%	0.00%	0.00%	0.00%
Cash Return on Invested Capital (CROIC)	16.61%	2.53%	0.00%	0.00%	0.00%	-97.54%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	3.64%	5.09%	0.00%	0.00%	0.00%	4.59%	0.00%	0.00%	0.00%
Return on Assets (ROA)	2.08%	0.99%	0.00%	0.00%	0.00%	-0.48%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	11.70%	13.14%	0.00%	0.00%	0.00%	19.11%	0.00%	0.00%	0.00%
Return on Equity Simple (ROE_SIMPLE)	3.25%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	52	50	-655	122	5.65	48	-37	56	36
NOPAT Margin	1.81%	1.65%	-22.54%	4.46%	0.22%	2.01%	-1.62%	2.57%	1.78%
Net Nonoperating Expense Percent (NNEP)	1.02%	1.14%	-45.48%	7.28%	4.11%	1.54%	0.00%	0.00%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	1.19%	1.18%	-	-	-	1.14%	-	-	-
Cost of Revenue to Revenue	88.24%	86.18%	85.96%	85.75%	85.66%	84.47%	84.12%	82.83%	83.50%
SG&A Expenses to Revenue	9.99%	11.23%	12.08%	11.96%	14.02%	12.65%	18.19%	13.50%	13.96%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	9.99%	11.23%	12.08%	11.96%	14.02%	12.65%	18.19%	13.50%	13.96%
Earnings before Interest and Taxes (EBIT)	51	79	57	62	8.07	68	-52	80	52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	96	137	110	115	61	124	3.70	135	107
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.88	1.80	1.56	1.22	0.37	1.19	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.27	0.26	0.00	0.00	0.00	0.08	0.00	0.00	0.00
Price to Earnings (P/E)	55.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.81%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.58	1.31	1.20	1.08	0.76	1.03	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.49	0.49	0.00	0.00	0.00	0.49	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	12.05	13.11	0.00	0.00	0.00	11.60	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	21.26	26.86	0.00	0.00	0.00	29.19	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	26.98	38.37	0.00	0.00	0.00	41.70	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	28.36	233.17	0.00	0.00	0.00	20.38	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	8.97	52.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	1.58	1.60	1.78	1.76	1.64	5.86	0.00	0.00	0.00
Long-Term Debt to Equity	1.55	1.57	1.75	1.73	1.61	5.81	0.00	0.00	0.00
Financial Leverage	1.38	2.72	1.76	1.75	1.61	5.84	0.00	0.00	0.00
Leverage Ratio	3.52	5.06	3.57	3.49	3.59	9.03	0.00	0.00	0.00
Compound Leverage Factor	0.62	1.55	0.05	0.56	-31.03	-1.96	0.00	0.00	0.00
Debt to Total Capital	61.27%	61.48%	64.00%	63.81%	62.18%	85.42%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	1.12%	1.14%	1.09%	1.10%	1.17%	0.77%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	60.16%	60.34%	62.91%	62.72%	61.01%	84.65%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.07%	0.09%	0.10%	0.14%	0.16%	0.66%	0.00%	0.00%	0.00%
Common Equity to Total Capital	38.65%	38.44%	35.90%	36.04%	37.66%	13.92%	0.00%	0.00%	0.00%
Debt to EBITDA	5.57	6.23	0.00	0.00	0.00	9.69	0.00	0.00	0.00
Net Debt to EBITDA	5.46	6.09	0.00	0.00	0.00	9.65	0.00	0.00	0.00
Long-Term Debt to EBITDA	5.46	6.12	0.00	0.00	0.00	9.60	0.00	0.00	0.00
Debt to NOPAT	12.46	18.24	0.00	0.00	0.00	34.83	0.00	0.00	0.00
Net Debt to NOPAT	12.22	17.82	0.00	0.00	0.00	34.70	0.00	0.00	0.00
Long-Term Debt to NOPAT	12.24	17.91	0.00	0.00	0.00	34.52	0.00	0.00	0.00
Altman Z-Score	2.69	2.40	0.43	0.35	0.10	1.72	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	0.31%	1.39%	0.27%	0.39%	0.43%	4.54%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	1.73	1.33	1.35	1.33	1.26	1.17	0.00	0.00	0.00
Quick Ratio	0.71	0.76	0.84	0.88	0.84	0.72	0.00	0.00	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	483	12	-5,117	-4,291	-4,099	0.00	0.00	0.00	0.00
Operating Cash Flow to CapEx	576.21%	591.81%	135.94%	-64.12%	-361.47%	964.71%	188.23%	-120.32%	223.56%
Free Cash Flow to Firm to Interest Expense	11.57	0.22	-91.27	-81.83	-52.72	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	2.43	1.65	0.49	-0.29	-1.01	1.96	0.40	-0.32	0.51
Operating Cash Flow Less CapEx to Interest Expense	2.01	1.37	0.13	-0.74	-1.29	1.75	0.19	-0.58	0.28
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	2.06	1.97	0.00	0.00	0.00	1.60	0.00	0.00	0.00
Accounts Receivable Turnover	12.06	11.80	0.00	0.00	0.00	10.01	0.00	0.00	0.00
Inventory Turnover	22.54	18.55	0.00	0.00	0.00	18.35	0.00	0.00	0.00
Fixed Asset Turnover	56.08	45.41	0.00	0.00	0.00	35.89	0.00	0.00	0.00
Accounts Payable Turnover	13.42	12.23	0.00	0.00	0.00	11.52	0.00	0.00	0.00
Days Sales Outstanding (DSO)	30.25	30.94	0.00	0.00	0.00	36.46	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	16.20	19.67	0.00	0.00	0.00	19.89	0.00	0.00	0.00
Days Payable Outstanding (DPO)	27.20	29.85	0.00	0.00	0.00	31.68	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	19.25	20.77	0.00	0.00	0.00	24.67	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	3,673	4,226	4,461	4,413	4,104	4,188	0.00	0.00	0.00
Invested Capital Turnover	3.05	2.68	0.00	0.00	0.00	2.11	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	-431	38	4,461	4,413	4,104	0.00	0.00	0.00	0.00
Enterprise Value (EV)	5,791	5,543	5,364	4,759	3,117	4,296	0.00	0.00	0.00
Market Capitalization	3,165	2,965	2,517	1,946	580	693	693	693	693
Book Value per Share	$9.64	$9.46	$9.42	$9.34	$8.93	$4.96	$0.00	$0.00	$0.00
Tangible Book Value per Share	($7.15)	($10.54)	($11.08)	($10.96)	($10.81)	($24.65)	$0.00	$0.00	$0.00
Total Capital	4,365	4,287	4,497	4,438	4,163	4,201	0.00	0.00	0.00
Total Debt	2,675	2,636	2,878	2,832	2,588	3,588	0.00	0.00	0.00
Total Long-Term Debt	2,626	2,587	2,829	2,783	2,540	3,556	0.00	0.00	0.00
Net Debt	2,623	2,574	2,842	2,807	2,530	3,575	0.00	0.00	0.00
Capital Expenditures (CapEx)	18	15	20	24	22	17	18	21	18
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,067	452	459	400	318	227	0.00	0.00	0.00
Debt-free Net Working Capital (DFNWC)	1,120	513	495	426	376	240	0.00	0.00	0.00
Net Working Capital (NWC)	1,071	465	446	377	328	208	0.00	0.00	0.00
Net Nonoperating Expense (NNE)	23	35	-646	102	52	55	94	53	58
Net Nonoperating Obligations (NNO)	1,983	2,574	2,842	2,807	2,530	3,575	0.00	0.00	0.00
Total Depreciation and Amortization (D&A)	45	58	53	53	53	56	56	56	56
Debt-free, Cash-free Net Working Capital to Revenue	9.00%	4.01%	0.00%	0.00%	0.00%	2.58%	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	9.44%	4.56%	0.00%	0.00%	0.00%	2.72%	0.00%	0.00%	0.00%
Net Working Capital to Revenue	9.03%	4.12%	0.00%	0.00%	0.00%	2.36%	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.15	$0.11	($0.04)	$0.10	($0.26)	($0.05)	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	201.01M	193.00M	198.49M	197.52M	175.53M	117.87M	0.00	0.00	0.00
Adjusted Diluted Earnings per Share	$0.14	$0.11	($0.04)	$0.10	($0.26)	($0.05)	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	214.93M	193.00M	198.49M	208.99M	175.53M	117.87M	0.00	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	174.25M	174.97M	174.13M	171.46M	171.32M	0.00	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	36	50	40	44	5.65	48	-37	56	36
Normalized NOPAT Margin	1.23%	1.65%	1.37%	1.60%	0.22%	2.01%	-1.62%	2.57%	1.78%
Pre Tax Income Margin	0.31%	0.79%	0.03%	0.37%	-2.70%	-0.62%	-6.02%	0.00%	-1.31%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.21	1.44	1.01	1.19	0.10	0.82	-0.62	1.00	0.66
NOPAT to Interest Expense	1.25	0.92	-11.69	2.32	0.07	0.58	-0.44	0.70	0.46
EBIT Less CapEx to Interest Expense	0.79	1.16	0.66	0.74	-0.18	0.62	-0.84	0.74	0.43
NOPAT Less CapEx to Interest Expense	0.83	0.64	-12.05	1.87	-0.21	0.37	-0.65	0.44	0.23
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	13.56%	-14.45%	0.00%	0.00%	0.00%	-0.41%	0.00%	0.00%	0.00%

Frequently Asked Questions About BrightSpring Health Services' Financials

When does BrightSpring Health Services's fiscal year end?

According to the most recent income statement we have on file, BrightSpring Health Services' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has BrightSpring Health Services' net income changed over the last 2 years?

BrightSpring Health Services' net income appears to be on a downward trend, with a most recent value of -$20.52 million in 2024, falling from -$54.22 million in 2022. The previous period was -$156.84 million in 2023.

What is BrightSpring Health Services's operating income?

BrightSpring Health Services's total operating income in 2024 was $206.37 million, based on the following breakdown:

Total Gross Profit: $1.59 billion
Total Operating Expenses: $1.38 billion

How has BrightSpring Health Services revenue changed over the last 2 years?

Over the last 2 years, BrightSpring Health Services' total revenue changed from $7.72 billion in 2022 to $11.27 billion in 2024, a change of 45.9%.

How much debt does BrightSpring Health Services have?

BrightSpring Health Services' total liabilities were at $4.27 billion at the end of 2024, a 13.1% decrease from 2023, and a 13.1% decrease since 2023.

How much cash does BrightSpring Health Services have?

In the past 1 years, BrightSpring Health Services' cash and equivalents has ranged from $13.07 million in 2023 to $61.25 million in 2024, and is currently $61.25 million as of their latest financial filing in 2024.

How has BrightSpring Health Services' book value per share changed over the last 2 years?

Over the last 2 years, BrightSpring Health Services' book value per share changed from 0.00 in 2022 to 9.46 in 2024, a change of 946.4%.

Related Companies

This page (NASDAQ:BTSGU) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BrightSpring Health Services (BTSGU) Financials

Frequently Asked Questions About BrightSpring Health Services' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BrightSpring Health Services (BTSGU) Financials

Annual Income Statements for BrightSpring Health Services

Quarterly Income Statements for BrightSpring Health Services

Annual Cash Flow Statements for BrightSpring Health Services

Quarterly Cash Flow Statements for BrightSpring Health Services

Annual Balance Sheets for BrightSpring Health Services

Quarterly Balance Sheets for BrightSpring Health Services

Annual Metrics And Ratios for BrightSpring Health Services

Quarterly Metrics And Ratios for BrightSpring Health Services

Frequently Asked Questions About BrightSpring Health Services' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools